MBA Candidate at Northwestern University’s Kellogg School of Management, Class of 2025
Phillip Cox is currently pursuing his MBA at the Kellogg School of Management at Northwestern University. His academic journey began at UCLA in the Bioengineering program, where he actively participated in BMES, the Regents Scholar Society, and the Healthy Campus Initiative. Phillip’s interest in biotechnology extended to internships at Genentech and Amgen during two summers, alongside engaging in impactful undergraduate research. Following completion of his undergraduate studies in Bioengineering in 2017, his career led him to Boston, Massachusetts, where he joined Moderna, a pioneering mRNA startup comprising around 400 employees at the time.
From 2017 to 2023, Phillip assumed diverse roles within Manufacturing, Process Development, and Strategy and Operations at Moderna. Notably, he played a key role in driving the company’s global expansion, exponential employee growth, and the rapid development and roll-out of Moderna’s COVID vaccine and subsequent boosters amidst the global pandemic. His last role was on the Technical Development Strategic Operations team where he was instrumental in leading integration of cutting-edge DNA manufacturing technology into various business units at Moderna; a result of the company’s acquisition of OriCiro Genomics. Phillip is now pursuing an MBA to become a strategic business leader equipped with the skills necessary to advance new breakthrough medical innovations and lead efforts to close health equity gaps across communities.